AdipoRon attenuates lipopolysaccharide-induced acute lung injury with reduced early fibroproliferative remodeling.

Kim IK, Lee H, Lee SH, Kim SW.

Open source

DOI
10.1016/j.intimp.2026.117443
Published
2026-09-17
Container
Int Immunopharmacol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2026.117443,
  title = {AdipoRon attenuates lipopolysaccharide-induced acute lung injury with reduced early fibroproliferative remodeling.},
  author = {Kim IK and  Lee H and  Lee SH and  Kim SW.},
  year = {2026},
  journal = {Int Immunopharmacol},
  doi = {10.1016/j.intimp.2026.117443},
  url = {https://doi.org/10.1016/j.intimp.2026.117443}
}

RIS

TY  - JOUR
TI  - AdipoRon attenuates lipopolysaccharide-induced acute lung injury with reduced early fibroproliferative remodeling.
AU  - Kim IK
AU  -  Lee H
AU  -  Lee SH
AU  -  Kim SW.
PY  - 2026
JO  - Int Immunopharmacol
DO  - 10.1016/j.intimp.2026.117443
UR  - https://doi.org/10.1016/j.intimp.2026.117443
ER  - 

APA

IK, K., H, L., SH, L., & SW., K. (2026). AdipoRon attenuates lipopolysaccharide-induced acute lung injury with reduced early fibroproliferative remodeling.. Int Immunopharmacol. https://doi.org/10.1016/j.intimp.2026.117443

Source records